Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M425Revenue (TTM) $M101Net Margin (%)-56.0Altman Z-Score-2.1
Enterprise Value $M354EPS (TTM) $-0.6Operating Margin %-53.8Piotroski F-Score5
P/E(ttm)--Beneish M-Score-0.9Pre-tax Margin (%)-56.0Higher ROA y-yN
Price/Book4.310-y EBITDA Growth Rate %--Quick Ratio3.3Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %-45.7Current Ratio3.8Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-41.5Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-69.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M92.7ROIC % (ttm)-424.0Gross Margin Increase y-yY

Gurus Latest Trades with PACB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PACBRonald Muhlenkamp 2015-12-31 Sold Out -0.01%$6.13 - $13.45
($9.11)
$ 4.75-48%Sold Out0
PACBRonald Muhlenkamp 2015-09-30 Buy 0.01%$3.66 - $5.8
($4.89)
$ 4.75-3%New holding11,125
PACBFirst Eagle Investment 2012-09-30 Sold Out -0.0013%$1.7 - $2.32
($1.96)
$ 4.75142%Sold Out0
PACBFirst Eagle Investment 2012-03-31 Buy $2.94 - $5.04
($3.71)
$ 4.7528%New holding150,000
PACBGeorge Soros 2011-09-30 Sold Out -0.0018%$3.55 - $12.24
($7.91)
$ 4.75-40%Sold Out0
PACBGeorge Soros 2011-06-30 Buy $10.44 - $13.53
($11.8)
$ 4.75-60%New holding10,700
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PACB is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


PACB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phillips James MichaelSVP, Research & Development 2016-10-28Sell20,000$8.44-43.72view
Phillips James MichaelSVP, Research & Development 2016-07-29Sell20,000$8.45-43.79view
Phillips James MichaelSVP, Research & Development 2016-04-25Sell20,000$10.29-53.84view
Phillips James MichaelSVP, Research & Development 2015-08-07Sell16,689$4.613.04view
Phillips James MichaelSVP, Research & Development 2015-03-02Buy1,877$4.91-3.26view
CORCORAN KEVIN PSVP, Market Development 2015-03-02Buy2,816$4.91-3.26view
Dow Brian BVP and PAO 2015-03-02Buy2,503$4.91-3.26view
Ericson William W.Director 2014-08-19Buy39,299$5.14-7.59view
Ericson William W.Director 2014-08-18Buy135,155$5.09-6.68view
Ericson William W.Director 2014-08-14Buy77,822$5-5view

Quarterly/Annual Reports about PACB:

News about PACB:

Articles On GuruFocus.com
Meridian Funds Comments on Pacific Biosciences of California Inc. Mar 08 2016 
Weekly CEO Buys Highlight: CLR, CLMS, OPK, PACB, GAIN Dec 16 2013 
Weekly CEO Buys Highlight: OPK, PACB, CUBI, ARCP, RLYP Nov 25 2013 
Weekly CEO Buys Highlight: PHII, TUES, PACB, IPHI, WMC Dec 09 2012 
Weekly CEO Buys Highlight: PACB, AKS, EPIQ, GGS, TPGI Dec 02 2012 
Weekly CEO Buys Highlight: FFIN, STEC, MPO, PACB, TPGI Nov 25 2012 
Weekly CEO Buys Highlight: SUNS, PACB, GM, NPO, DGX Aug 11 2012 

More From Other Websites
Pacific Biosciences (PACB) to Sell 10 PacBio Sequel Systems Jan 17 2017
Novogene Agrees to Buy Ten PacBio Sequel Systems for DNA Sequencing Services Jan 16 2017
More Than 115 Presentations and Posters Feature PacBio SMRT Sequencing to Decipher Complex Plant and... Jan 12 2017
UPDATE -- Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and... Jan 09 2017
Pacific Biosciences Improves Key Applications on the Sequel System with New Chemistry and Software... Jan 09 2017
GrandOmics Endorses Pacific Biosciences of California (PACB) Sequel System With New Purchase Jan 05 2017
GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine... Jan 04 2017
GrandOmics Biosciences Expands Investment in PacBio’s Sequel Systems for Precision Medicine... Jan 04 2017
ETFs with exposure to Pacific Biosciences of California, Inc. : December 19, 2016 Dec 19 2016
Pacific Biosciences Terminates SMRT Agreement with Roche Dec 16 2016
Valeant, HiMax Lead Thursday’s 52-Week Low Club Dec 15 2016
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Files SEC form 8-K, Termination of a Material Definitive... Dec 15 2016
PacBio Announces Termination of Agreement with Roche Diagnostics Dec 15 2016
Is Pacific Biosciences of California (PACB) a Good Stock to Buy? Dec 09 2016
ETFs with exposure to Pacific Biosciences of California, Inc. : December 8, 2016 Dec 08 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)